Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring

Pharmacology and Therapeutics · Published 2026-07-24 · DOI 10.1016/j.pharmthera.2026.109089

Authors (14)

Yafeng Li, Wenzhu Song, Chengyu Huan, Keman Xu, Juan Sun, Xin Zhen, Hua Ouyang, Hairong Tang, Qiuxia Fan, Wenqiang Zhi, Yuanmin Chai, Ruilin Li, Hong Wang, Xiaofeng Yang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Li, Y., Song, W., Huan, C., et al. (2026). Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring. Pharmacology and Therapeutics. https://doi.org/10.1016/j.pharmthera.2026.109089

Related articles

• The aftermath of alcohol misuse: Linking cellular damage, suboptimal micronutrient nutrition, and organ dysfunction · Pharmacology and Therapeutics · 2026 · Same journal
• A dive into the untapped potential of marine compounds in counteracting neurodegeneration · Pharmacology and Therapeutics · 2026 · Same journal
• Mathematical modeling of T cell exhaustion in the tumor microenvironment · Pharmacology and Therapeutics · 2026 · Same journal
• C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy · Pharmacology and Therapeutics · 2026 · Same journal
• Circular RNA serves as an upstream regulator of the miRNA//ABCC1 axis in human cancers · Pharmacology and Therapeutics · 2026 · Same journal
• Clinical relevance of per-particle atherogenicity of triglyceride-rich lipoproteins, Lp(a) and LDL for cardiovascular risk · Pharmacology and Therapeutics · 2026 · Same journal
• Therapeutic potential of targeting novel signaling pathways in regulating chronic inflammation in obstructive lung disorders · Pharmacology and Therapeutics · 2026 · Same journal
• Incretin-based therapies: Effects on plasma lipids and potential mechanisms · Pharmacology and Therapeutics · 2026 · Same journal
• Pharmacological activation of cGAS-STING pathway to reverse cancer drug resistance · Pharmacology and Therapeutics · 2026 · Same journal
• RNA renaissance: Harnessing non-coding RNA therapeutics for hepatocellular carcinoma · Pharmacology and Therapeutics · 2025 · Same journal